EP1976540A1 - Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts - Google Patents

Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts

Info

Publication number
EP1976540A1
EP1976540A1 EP06820070A EP06820070A EP1976540A1 EP 1976540 A1 EP1976540 A1 EP 1976540A1 EP 06820070 A EP06820070 A EP 06820070A EP 06820070 A EP06820070 A EP 06820070A EP 1976540 A1 EP1976540 A1 EP 1976540A1
Authority
EP
European Patent Office
Prior art keywords
treatment
treatment substance
magnesium sulfate
warts
magnesium salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06820070A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1976540A4 (en
Inventor
Kari Honkanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medgenerics Oy
Original Assignee
Medgenerics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medgenerics Oy filed Critical Medgenerics Oy
Publication of EP1976540A1 publication Critical patent/EP1976540A1/en
Publication of EP1976540A4 publication Critical patent/EP1976540A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP06820070A 2006-01-24 2006-11-29 THERAPEUTIC SUBSTANCE CONTAINING MAGNESIUM SALTS FOR THE TREATMENT OF TUMORS OR SIMILAR, AND USE OF MAGNESIUM SALTS Withdrawn EP1976540A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20060065A FI119101B (fi) 2006-01-24 2006-01-24 Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
PCT/FI2006/000394 WO2007085681A1 (en) 2006-01-24 2006-11-29 Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts

Publications (2)

Publication Number Publication Date
EP1976540A1 true EP1976540A1 (en) 2008-10-08
EP1976540A4 EP1976540A4 (en) 2010-07-28

Family

ID=35883876

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06820070A Withdrawn EP1976540A4 (en) 2006-01-24 2006-11-29 THERAPEUTIC SUBSTANCE CONTAINING MAGNESIUM SALTS FOR THE TREATMENT OF TUMORS OR SIMILAR, AND USE OF MAGNESIUM SALTS

Country Status (3)

Country Link
EP (1) EP1976540A4 (zh)
FI (1) FI119101B (zh)
WO (1) WO2007085681A1 (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499984A (en) * 1975-04-16 1978-02-01 Unigate Foods Ltd Dietary foods
WO1995031991A2 (en) * 1994-05-25 1995-11-30 Giampiero Valletta Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
JPH08502976A (ja) * 1992-10-29 1996-04-02 シー−ピー テクノロジー リミテッド パートナーシップ カルシウムおよび硫酸塩を含有した組成物および複合体、その合成法、これを用いた治療法、これを含んでなる化粧用調製物
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499984A (en) * 1975-04-16 1978-02-01 Unigate Foods Ltd Dietary foods
WO1995031991A2 (en) * 1994-05-25 1995-11-30 Giampiero Valletta Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1976, ZAROW: "Clinical Observations on the Treatment of Verruca Peruana with Magnesium Sulfate" XP002105003 retrieved from BIOSIS accession no. PREV197764045827 Database accession no. PREV197764045827 *
DATABASE EMBASE [Online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1957, NAGNEEBEDA N I: "The treatment of far advanced malignant tumours with magnesium sulphate" XP002586659 Database accession no. EMB-0007482898 & VOPROSY ONKOLOGII 1957, vol. 3, no. 5, 1957, pages 562-567, ISSN: 0507-3758 *
MILLS B J ET AL: "Inhibition of tumor growth by magnesium depletion of rats." THE JOURNAL OF NUTRITION APR 1984 LNKD- PUBMED:6716176, vol. 114, no. 4, April 1984 (1984-04), pages 739-745, XP002586660 ISSN: 0022-3166 *
See also references of WO2007085681A1 *

Also Published As

Publication number Publication date
EP1976540A4 (en) 2010-07-28
FI20060065A (fi) 2007-07-25
WO2007085681A1 (en) 2007-08-02
FI20060065A0 (fi) 2006-01-24
FI119101B (fi) 2008-07-31

Similar Documents

Publication Publication Date Title
US5589480A (en) Topical application of opioid analgesic drugs such as morphine
EA032439B1 (ru) Композиции и способы для лечения поверхностных ран
CN108853312A (zh) 聚桂醇外用凝胶及其制备方法
DK166479B (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
RU2006139819A (ru) Применение симетикона для предрасположенных к запорам пациентов
US5278172A (en) Method and composition for treating tendon or joint inflammation using a vasodilator
CN102188572B (zh) 一种治疗骨伤的中药
CN103977194A (zh) 能有效治疗创面感染的外用药在制备治疗糖尿病足药物中的应用
US5576329A (en) Method for treating tendon or joint inflammation with papaverine HCL
CN109700856A (zh) 一种具有活血通络、舒筋止痛的中药外用方剂
EP2322177B1 (en) Use of a preparation based on nifedipine for treating vaginismus
JPH08500343A (ja) セシウムイオンを用いた治療方法
EP1976540A1 (en) Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts
CN1669562A (zh) 筋骨康复膏及其制备方法
CN103585257B (zh) 一种治疗骨折的中药散剂
CN102078516B (zh) 一种治疗骨伤的中药
CN102512650A (zh) 一种治疗面神经麻痹的外用药物
CN104056080A (zh) 一种治疗脑血栓后遗症的中药组合物
RU2357747C1 (ru) Способ лечения больных псориатической болезнью
RU2181995C1 (ru) Способ лечения миофасциального болевого синдрома
CN107569577A (zh) 一种药物组合物在制备治疗三叉神经痛的药物中的应用
CN103110748B (zh) 一种治疗性病的复方中药组合物及其用途
RU2200557C1 (ru) Способ лечения гипертрофических и келоидных рубцов
RU2182006C2 (ru) Способ лечения ревматоидного артрита
Efraimidis et al. Efficacy of laser application for the rehabilitation of patients with Bell's palsy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HONKANEN, KARI

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/02 20060101ALN20100615BHEP

Ipc: A61K 9/00 20060101ALI20100615BHEP

Ipc: A61P 35/00 20060101ALI20100615BHEP

Ipc: A61P 17/12 20060101ALI20100615BHEP

Ipc: A61K 33/06 20060101AFI20070906BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100628

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110126